A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

September 28, 2026

Study Completion Date

October 12, 2026

Conditions

Local Analgesia Via Nerve Block

Interventions

DRUG

Bupivacaine Liposome Injection

Bupivacaine Liposome Injection Low Dose or Moderate Dose or High Dose

DRUG

Bupivacaine Hydrochloride Injection

Bupivacaine Hydrochloride Injection Low Dose or Moderate Dose or High Dose

Trial Locations (1)

Zhongshan Hospital Affiliated to Fudan University, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY